Results 201 to 210 of about 7,765,653 (401)

Alternative Medicine Use by Individuals with Major Depression [PDF]

, 2001
JianLi Wang, Scott B. Patten, Margaret L. Russell   +2 more
openalex   +1 more source

How alternative is alternative medicine? [PDF]

Nature Medicine, 2007
openaire   +3 more sources

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Traditional Complementary and Alternative Medicine Utilization Among Korean American Older Adults: A Multilevel Analysis. [PDF]

J Appl Gerontol
Yi G, Jang Y, Martinez L.
europepmc   +1 more source

Alternative and complementary medicine: A source of improved therapies for asthma? A challenge for redefining the specialty?

, 2000
Renata J.M. Engler
openalex   +1 more source

Use of Alternative Medicine for Cancer and Its Impact on Survival.

Journal of the National Cancer Institute, 2017
Skyler B Johnson, Henry S. Park, C. Gross, James B. Yu   +3 more
semanticscholar   +1 more source

The demarcation problem and alternative medicine [PDF]

, 2003
Gillies, D.
core  

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

<i>Chlorella vulgaris</i>, a representative edible algae as integrative and alternative medicine. [PDF]

Integr Med Res
Heo Y, Kim MY, Cho JY.
europepmc   +1 more source

Complementary and alternative medicine for children: does it work? [PDF]

, 2001
Kathi J. Kemper
openalex   +1 more source